179 related articles for article (PubMed ID: 9600324)
1. Comparison of D2 and D3 dopamine receptor affinity of dopaminergic compounds in rat brain.
Flietstra RJ; Levant B
Life Sci; 1998; 62(20):1825-31. PubMed ID: 9600324
[TBL] [Abstract][Full Text] [Related]
2. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
Gackenheimer SL; Schaus JM; Gehlert DR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
Hillefors M; von Euler G
Neurochem Int; 2001 Jan; 38(1):31-42. PubMed ID: 10913686
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
[TBL] [Abstract][Full Text] [Related]
5. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
[TBL] [Abstract][Full Text] [Related]
6. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors.
Levant B; Grigoriadis DE; De Souza EB
Eur J Pharmacol; 1995 May; 278(3):243-7. PubMed ID: 7589161
[TBL] [Abstract][Full Text] [Related]
7. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
[TBL] [Abstract][Full Text] [Related]
8. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors.
Levant B; DeSouza EB
Synapse; 1993 May; 14(1):90-5. PubMed ID: 8099762
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.
Bowery BJ; Razzaque Z; Emms F; Patel S; Freedman S; Bristow L; Kulagowski J; Seabrook GR
Br J Pharmacol; 1996 Dec; 119(7):1491-7. PubMed ID: 8968560
[TBL] [Abstract][Full Text] [Related]
10. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
Seeman P; Ko F; Willeit M; McCormick P; Ginovart N
Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
[TBL] [Abstract][Full Text] [Related]
11. Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study.
Bancroft GN; Morgan KA; Flietstra RJ; Levant B
Neuropsychopharmacology; 1998 Apr; 18(4):305-16. PubMed ID: 9509498
[TBL] [Abstract][Full Text] [Related]
12. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study.
Cagnotto A; Parotti L; Mennini T
Eur J Pharmacol; 1996 Oct; 313(1-2):63-7. PubMed ID: 8905329
[TBL] [Abstract][Full Text] [Related]
13. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
Piercey MF; Walker EL; Feldpausch DL; Camacho-Ochoa M
Neurosci Lett; 1996 Nov; 219(2):138-40. PubMed ID: 8971799
[TBL] [Abstract][Full Text] [Related]
14. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat.
Stanwood GD; McElligot S; Lu L; McGonigle P
Neurosci Lett; 1997 Feb; 223(1):13-6. PubMed ID: 9058411
[TBL] [Abstract][Full Text] [Related]
15. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
Gurevich EV; Bordelon Y; Shapiro RM; Arnold SE; Gur RE; Joyce JN
Arch Gen Psychiatry; 1997 Mar; 54(3):225-32. PubMed ID: 9075463
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
17. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
Malmberg ; Mikaels ; Mohell N
J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
[TBL] [Abstract][Full Text] [Related]
18. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
19. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
20. Lack of discrimination by agonists for D2 and D3 dopamine receptors.
Burris KD; Pacheco MA; Filtz TM; Kung MP; Kung HF; Molinoff PB
Neuropsychopharmacology; 1995 Jul; 12(4):335-45. PubMed ID: 7576010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
